Comparing 3 techniques for eliciting patient values for decision making about prostate-specific antigen screening: a

Michael Patrick Pignone1, Kirsten Howard, Alison Tytell Brenner

  • 1Cecil G. Sheps Center for Health Services Research, Universityof North Carolina at Chapel Hill, 725 Martin LutherKing Jr Blvd, Chapel Hill, NC 27599, USA. pignone@med.unc.edu

JAMA Internal Medicine
|February 13, 2013
PubMed
Summary

Different methods for clarifying patient values before prostate-specific antigen (PSA) screening influence decision-making. The rating and ranking task highlighted reducing prostate cancer death as most important, but intent for PSA testing remained similar across all methods.

Related Concept Videos